Stephen F. Carter

University of Manchester, Manchester, England, United Kingdom 
"Stephen Carter"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Altomare D, Ferrari C, Caroli A, et al. (2019) Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology
Carter SF, Herholz K, Rosa-Neto P, et al. (2019) Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine
Asghar M, Hinz R, Herholz K, et al. (2019) Dual-phase [18F]florbetapir in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 46: 304-311
Carter SF, Chiotis K, Nordberg A, et al. (2019) Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356
Legdeur N, Badissi M, Carter SF, et al. (2018) Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289
Konijnenberg E, Carter SF, Ten Kate M, et al. (2018) The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy. 10: 75
Rodriguez-Vieitez E, Carter SF, Chiotis K, et al. (2016) Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, et al. (2016) Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology
Schöll M, Carter SF, Westman E, et al. (2015) Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404
Zwan MD, Rinne JO, Hasselbalch SG, et al. (2015) Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology
See more...